Journal Article

Prostaglandin E receptor <i>EP<sub>3</sub></i> deficiency modifies tumor outcome in mouse two-stage skin carcinogenesis

Yutaka Shoji, Mami Takahashi, Nobuo Takasuka, Naoko Niho, Tomohiro Kitamura, Hidetaka Sato, Takayuki Maruyama, Yukihiko Sugimoto, Shuh Narumiya, Takashi Sugimura and Keiji Wakabayashi

in Carcinogenesis

Volume 26, issue 12, pages 2116-2122
Published in print December 2005 | ISSN: 0143-3334
Published online July 2005 | e-ISSN: 1460-2180 | DOI:
Prostaglandin E receptor EP3 deficiency modifies tumor outcome in mouse two-stage skin carcinogenesis

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics


Show Summary Details


We have recently shown that the prostaglandin E2 (PGE2) receptor EP3 plays an important role in suppression of colon cancer cell proliferation and that its deficiency enhances late stage colon carcinogenesis. Here we examined the effects of EP3-deficiency on two-stage skin carcinogenesis. 7,12-Dimethylbenz[a]anthracene (50 µg/200 µl of acetone) was thus applied to the back skin of female EP3-knockout and wild-type mice at 8 weeks of age, followed by treatment with 12-O-tetradecanoylphorbol-13-acetate (5 µg/200 µl of acetone) twice a week for 25 weeks. First tumor appearance was observed in EP3-knockout mice at week 10, which was 3 weeks later than in EP3 wild-type mice, and multiplicity observed at week 11 was significantly lower in the EP3-knockout case. However, histological examination showed that the tumor incidence and multiplicity at week 25 were not significantly changed in knockout mice and wild-type mice (incidence, 19/19 versus 23/24; multiplicity, 3.58 ± 0.51 versus 3.17 ± 0.63, respectively). Interestingly, there were no squamous cell carcinomas (SCCs) in the EP3-knockout mice, while SCCs were observed in 3 out of 24 wild-type mice. Furthermore, benign keratoacanthomas only developed in EP3-knockout mice (6/19 versus 0/24, P < 0.01). The results suggest that PGE2 receptor EP3 signaling might contribute to development of SCCs in the skin.

Keywords: ACF, aberrant crypt foci; AOM, azoxymethane; COX, cyclooxygenase; DMBA, 7,12-dimethylbenz[a]anthracene; PGE2, prostaglandin E2; SCC, squamous cell carcinoma; TPA, 12-O-tetradecanoylphorbol-13-acetate

Journal Article.  4395 words.  Illustrated.

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.